Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 55

1.

Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.

Rapp SR, Espeland MA, Shumaker SA, Henderson VW, Brunner RL, Manson JE, Gass ML, Stefanick ML, Lane DS, Hays J, Johnson KC, Coker LH, Dailey M, Bowen D; WHIMS Investigators.

JAMA. 2003 May 28;289(20):2663-72.

PMID:
12771113
2.

The Women's Health Initiative trial and related studies: 10 years later: a clinician's view.

Gurney EP, Nachtigall MJ, Nachtigall LE, Naftolin F.

J Steroid Biochem Mol Biol. 2014 Jul;142:4-11. doi: 10.1016/j.jsbmb.2013.10.009. Epub 2013 Oct 27. Review.

PMID:
24172877
3.

Hormone therapy, dementia, and cognition: the Women's Health Initiative 10 years on.

Maki PM, Henderson VW.

Climacteric. 2012 Jun;15(3):256-62. doi: 10.3109/13697137.2012.660613. Review.

4.

The Women's Health Initiative Memory Study: findings and implications for treatment.

Craig MC, Maki PM, Murphy DG.

Lancet Neurol. 2005 Mar;4(3):190-4. Review.

PMID:
15721829
5.

New evidence regarding hormone replacement therapies is urgently required transdermal postmenopausal hormone therapy differs from oral hormone therapy in risks and benefits.

Modena MG, Sismondi P, Mueck AO, Kuttenn F, Lignières Bd, Verhaeghe J, Foidart JM, Caufriez A, Genazzani AR; TREAT.

Maturitas. 2005 Sep 16;52(1):1-10. Review.

PMID:
15963666
7.

Postmenopausal hormone therapy and cognition.

McCarrey AC, Resnick SM.

Horm Behav. 2015 Aug;74:167-72. doi: 10.1016/j.yhbeh.2015.04.018. Epub 2015 Apr 30. Review.

8.
9.

The WHI ten year's later: an epidemiologist's view.

Lacey JV Jr.

J Steroid Biochem Mol Biol. 2014 Jul;142:12-5. doi: 10.1016/j.jsbmb.2013.08.006. Epub 2013 Sep 9. Review.

PMID:
24029430
10.

Minireview: effects of different HT formulations on cognition.

Maki PM.

Endocrinology. 2012 Aug;153(8):3564-70. doi: 10.1210/en.2012-1175. Epub 2012 Jun 6. Review.

PMID:
22673228
11.

Postmenopausal hormone therapy and the risks of coronary heart disease, breast cancer, and stroke.

Prentice RL.

Semin Reprod Med. 2014 Nov;32(6):419-25. doi: 10.1055/s-0034-1384624. Epub 2014 Oct 16. Review.

12.

Cognitive changes after menopause: influence of estrogen.

Henderson VW.

Clin Obstet Gynecol. 2008 Sep;51(3):618-26. doi: 10.1097/GRF.0b013e318180ba10. Review.

13.
14.

Stroke findings in the Women's Health Initiative.

Wassertheil-Smoller S, Kaplan RC, Salazar CR.

Semin Reprod Med. 2014 Nov;32(6):438-46. doi: 10.1055/s-0034-1384627. Epub 2014 Oct 16. Review.

PMID:
25321421
15.

Breast Cancer and Menopausal Hormone Therapy by Race/Ethnicity and Body Mass Index.

Chlebowski RT, Anderson GL, Aragaki AK, Prentice R.

J Natl Cancer Inst. 2015 Nov 5;108(2). pii: djv327. doi: 10.1093/jnci/djv327. Print 2016 Feb. Review.

PMID:
26546117
16.

Hormone therapy and the risk of stroke: perspectives 10 years after the Women's Health Initiative trials.

Henderson VW, Lobo RA.

Climacteric. 2012 Jun;15(3):229-34. doi: 10.3109/13697137.2012.656254. Review.

17.

Menopausal hormone therapy and cancer: changing clinical observations of target site specificity.

Chlebowski RT, Anderson GL.

Steroids. 2014 Nov;90:53-9. doi: 10.1016/j.steroids.2014.06.001. Epub 2014 Jun 6. Review.

18.

Hormone replacement therapy and cognition: systematic review and meta-analysis.

LeBlanc ES, Janowsky J, Chan BK, Nelson HD.

JAMA. 2001 Mar 21;285(11):1489-99. Review.

PMID:
11255426
19.

Menopausal hormone therapy and breast cancer mortality: clinical implications.

Chlebowski RT, Anderson GL.

Ther Adv Drug Saf. 2015 Apr;6(2):45-56. doi: 10.1177/2042098614568300. Review.

20.

Use of medroxyprogesterone acetate for hormone therapy in postmenopausal women: is it safe?

Stanczyk FZ, Bhavnani BR.

J Steroid Biochem Mol Biol. 2014 Jul;142:30-8. doi: 10.1016/j.jsbmb.2013.11.011. Epub 2013 Nov 26. Review.

PMID:
24291402
Items per page

Supplemental Content

Write to the Help Desk